Radiation Recall in a Patient with Intrahepatic Cholangiocarcinoma: Case Report and a Literature Review

Radiation recall dermatitis (RRD) is a rare and poorly understood phenomenon, constituting an inflammatory skin reaction to a previously irradiated area of skin following the administration of certain agents, usually chemotherapy. Our patient developed RRD 66 years after receiving radiation therapy; to the best of our knowledge, this is the longest reported period in the literature. The mainstay of therapy is to withhold the agent that elicited the adverse reaction, followed by symptomatic management. Subjecting patients to further chemotherapy can provoke another episode of RRD. Therefore, clinical judgment in this regard is usually recommended.

[1]  A. Wolfson,et al.  Acute and Chronic Cutaneous Reactions to Ionizing Radiation Therapy , 2016, Dermatology and Therapy.

[2]  A. Milne,et al.  Radiation recall following cisplatin chemotherapy , 2013, British journal of haematology.

[3]  B. Haffty,et al.  Radiation recall 5 years after whole-breast irradiation for early-stage breast cancer secondary to initiation of rosuvastatin and amlodipine. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  H. Burris,et al.  Radiation Recall with Anticancer Agents , 2010, The oncologist.

[5]  F. Barlesi,et al.  Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis. , 2006, Lung cancer.

[6]  M. Fakih.  Gemcitabine-induced rectus abdominus radiation recall. , 2006, JOP : Journal of the pancreas.

[7]  N. Magné,et al.  Radiation recall: a well recognized but neglected phenomenon. , 2005, Cancer treatment reviews.

[8]  Biljana Ristić,et al.  Gemcitabine‐induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma , 2005, American journal of hematology.

[9]  P. Dayer,et al.  Radiation recall in a patient with breast cancer treated for tuberculosis , 2004, European Journal of Clinical Pharmacology.

[10]  R. Camidge,et al.  Characterizing the phenomenon of radiation recall dermatitis. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  W. Yeo,et al.  Radiation-Recall Skin Disorders Associated With the Use of Antineoplastic Drugs , 2000, American journal of clinical dermatology.

[12]  S. Vukelja,et al.  Paclitaxel-induced radiation recall dermatitis. , 1996, Medical and pediatric oncology.

[13]  R. Abadir,et al.  Radiation reaction recall following simvastatin therapy: a new observation. , 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

[14]  K. Stelzer,et al.  Radiation recall skin toxicity with bleomycin in a patient with kaposi sarcoma related to acquired immune deficiency syndrome , 1993, Cancer.

[15]  P. Nemechek,et al.  Radiation recall associated with vinblastine in a patient treated for kaposi sarcoma related to acquired immune deficiency syndrome , 1992, Cancer.

[16]  B. Parry.  Radiation recall induced by tamoxifen , 1992, The Lancet.

[17]  R. Stern,et al.  Cutaneous drug reactions: pathogenesis and clinical classification. , 1985, Journal of the American Academy of Dermatology.

[18]  J. Sullivan,et al.  Adriamycin-induced recall phenomenon 15 years after radiotherapy. , 1978, JAMA.

[19]  S. Jones,et al.  Adriamycin-irradiation cutaneous complications. , 1977, International journal of radiation oncology, biology, physics.

[20]  S. Aristizabal,et al.  Complications of irradiation related to apparent drug potentiation by adriamycin. , 1976, International journal of radiation oncology, biology, physics.